Issued Patents 2022
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11492403 | Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof | Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Arlene H. Sharpe, Nikolaos Patsoukis +2 more | 2022-11-08 |
| 11485787 | Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof | Rosemarie Dekruyff, Dale T. Umetsu, Sanhong Yu, Yanping Xiao | 2022-11-01 |
| 11413340 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gerhard Frey, Jennifer Marie Mataraza +2 more | 2022-08-16 |
| 11359020 | Agents that modulate immune cell activation and methods of use thereof | Arlene H. Sharpe, Yanping Xiao, Loise M. Francisco, Rosemarie Dekruyff, Dale T. Umetsu | 2022-06-14 |
| 11359013 | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway | Arlene H. Sharpe, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry | 2022-06-14 |
| 11261251 | Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor | Rafi Ahmed, Timothy David Jones, Francis Joseph Carr, James P. Gregson | 2022-03-01 |
| 11220545 | Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents | Yanping Xiao | 2022-01-11 |